You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucopolysaccharidosis VII

Showing 26 - 50 of 245
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucopolysaccharidosis II Trial in Netherlands, United States (DNL310)

Recruiting
  • Mucopolysaccharidosis II
  • Oakland, California
  • +4 more
Nov 14, 2022

Head and Neck Tumors, Congenital Abnormalities Trial in Paris (Tractography MRI)

Not yet recruiting
  • Head and Neck Neoplasms
  • Congenital Abnormalities
  • Tractography MRI
  • Paris, France
    Hôpital Necker-Enfants Malades
Mar 15, 2023

Mucopolysaccharidosis II Trial in Japan (JR-141)

Completed
  • Mucopolysaccharidosis II
  • Fukui, Japan
  • +18 more
Nov 10, 2022

Mucopolysaccharidosis II Trial in Porto Alegre, São Paulo (JR-141)

Completed
  • Mucopolysaccharidosis II
  • Porto Alegre, Brazil
  • +1 more
Nov 10, 2022

Mucopolysaccharidosis II Trial in Worldwide (JR-141, Idursulfase, JR-141 or Idursulfase)

Recruiting
  • Mucopolysaccharidosis II
  • Oakland, California
  • +8 more
Dec 2, 2022

Mucopolysaccharidosis II Trial in Japan (JR-141)

Active, not recruiting
  • Mucopolysaccharidosis II
  • Fukui, Japan
  • +19 more
Nov 30, 2022

Mucopolysaccharidosis Type 3 B Trial in Worldwide (rAAV9.CMV.hNAGLU)

Terminated
  • Mucopolysaccharidosis Type 3 B
  • rAAV9.CMV.hNAGLU
  • Columbus, Ohio
  • +3 more
Apr 29, 2022

Mucopolysaccharidosis Type VI Trial in Naples, Ankara (AAV2/8.TBG.hARSB)

Active, not recruiting
  • Mucopolysaccharidosis Type VI
  • AAV2/8.TBG.hARSB
  • Naples, Italy
  • +1 more
Nov 22, 2021

Recombinant Factor VII for Intractable Postpartum Haemorrhage

Completed
  • Post Partum Hemorrhage
  • recombinant factor VIIa
  • Cairo, Egypt
    Doaaa Alaa
Mar 18, 2022

Sanfilippo Syndrome A Trial (assessment)

Not yet recruiting
  • Sanfilippo Syndrome A
  • assessment
  • (no location specified)
Jun 6, 2021

Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)

Not yet recruiting
  • Mucopolysaccharidosis (MPS)
  • Hunter Syndrome
  • (no location specified)
Aug 8, 2022

Respiratory Cathepsins, Proteases Inhibitors and

Completed
  • Mucopolysaccharidoses
  • Sputum
  • Tracheal aspiration
  • Angers, France
  • +6 more
Jan 3, 2022

Mucopolysaccharidosis IV A, Morquio A Syndrome, MPS IVA Trial in Worldwide (BMN 110 - Weekly, BMN 110 - Every Other Week)

Completed
Has Results
  • Mucopolysaccharidosis IV A
  • +2 more
  • BMN 110 - Weekly
  • BMN 110 - Every Other Week
  • Phoenix, Arizona
  • +42 more
Jul 19, 2021

Mucopolysaccharidosis IH Trial in Milano (Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified

Active, not recruiting
  • Mucopolysaccharidosis IH
  • Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the α-L-iduronidase cDNA, in their final formulation medium.
  • Milano, Italy
    Ospedale San Raffaele
Aug 6, 2021

Epidermolysis Bullosa Dystrophica, Recessive Trial in Stanford, Aurora (FCX-007)

Active, not recruiting
Has Results
  • Epidermolysis Bullosa Dystrophica, Recessive
  • FCX-007
  • Stanford, California
  • +1 more
Sep 30, 2021

Mucopolysaccharidosis, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Campath-1H, Cyclophosphamide, Busulfan)

Completed
Has Results
  • Mucopolysaccharidosis
  • +12 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 9, 2018

Mucopolysaccharidosis IV Type A, Morquio A Syndrome, MPS IVA Trial in Worldwide (Vimizim® (elosulfase alfa))

Active, not recruiting
  • Mucopolysaccharidosis IV Type A
  • +2 more
  • Vimizim® (elosulfase alfa)
  • Phoenix, Arizona
  • +78 more
Dec 23, 2022

Hunter Syndrome Trial in India (Elaprase)

Recruiting
  • Hunter Syndrome
  • Elaprase
  • Thiruvananthapuram, Kerala, India
  • +4 more
May 5, 2022

Mucopolysaccharidosis Trial in Gaziantep (Enzyme Replacement Agent)

Completed
  • Mucopolysaccharidosis
  • Enzyme Replacement Agent
  • Gaziantep, None Selected, Turkey
    Serkan Usgu
Aug 7, 2021

Mucopolysaccharidosis II Trial in Oakland (JR-141)

Not yet recruiting
  • Mucopolysaccharidosis II
  • Oakland, California
    UCSF Benioff Children's Hospital Oakland
Oct 21, 2022

Mucopolysaccharidosis II Trial in Cincinnati (DNL310)

Enrolling by invitation
  • Mucopolysaccharidosis II
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 10, 2023

Striae Distensae Trial in Xi'an (Polylevolactic Acid Injection, 1565nm Non-ablative Fractional Laser, Polylevolactic Acid

Recruiting
  • Striae Distensae
  • Polylevolactic Acid Injection
  • +2 more
  • Xi'an, Shaanxi, China
    Dermatology Derpartment of Xijing Hospital
Apr 24, 2023

Cataract Trial in Monrovia (Cataract surgery)

Completed
Has Results
  • Cataract
  • Cataract surgery
  • Monrovia, Liberia
    PREVAIL JFK Hospital
Jun 7, 2021

Mucopolysaccharidosis VI Clinical Surveillance Program

Completed
  • Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)
    • Irvine, California
    • +49 more
    Apr 2, 2021

    Coagulation Testing in Patients Undergoing Cardiac Surgery

    Active, not recruiting
    • Congenital Heart Disease
    • Discarded blood samples
    • Discarded Urine Sample
    • Boston, Massachusetts
      Boston Children's Hospital
    Jan 7, 2023